InvestorsHub Logo

DewDiligence

03/10/21 3:46 PM

#237393 RE: DewDiligence #226664

AVEO +66% on FDA approval of Fotivda—(tivozanib)—in RCC:

https://www.businesswire.com/news/home/20210310005893/en